Does Defy Medical sell a GLP-1?
Defy places GLP-1 treatment within a broader medical weight-management practice. Its consultation and follow-up model deserve more attention than the list of available therapies.
The verdict
Defy may suit someone who wants a wider assessment and continuing provider contact. Before starting, establish which medical professional will manage the prescription, how often reviews occur and which exact drug product the pharmacy will supply.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Prescription
- Required
Defy Medical offers online weight-management consultations alongside hormone and other medical services. Its dedicated treatment pages discuss semaglutide and tirzepatide, and the patient portal supports enrollment and ongoing care.
Who writes the prescription, and what do they see?
The treatment pathway starts with a consultation with a Defy provider. The company describes tailoring treatment to health factors affecting weight. A website’s discussion of a medication does not identify the individual clinician assigned to a new patient; confirm that relationship during enrollment.
The published model describes personalized treatment and regular follow-up to refine the plan. It also offers other therapies. Ask which elements are medically necessary for the stated goal and whether the same clinician will review response and side effects over time.
What happens when the dose goes up?
Defy describes adjusting the plan through continued provider contact, without establishing a universal dose-increase schedule on the pages reviewed. The prescriber should decide whether a dose is maintained, increased or changed based on the individual assessment.
What the price includes
A comparable standing medication-inclusive monthly amount is not established on the treatment pages. The terms say Defy does not accept insurance, and clinical services, medicines and testing can involve separate costs. Clarify the complete care plan before agreeing to additional therapies.
What it claims, and what it cites
The semaglutide page describes a weekly injection; tirzepatide has a separate prescribing pathway. The reviewed material does not clearly establish the exact brand or compounded preparation supplied to every patient. Request that identity and the dispensing pharmacy before treatment.
Where it holds up, and where it does not
- Strength: Dedicated GLP-1 treatment pathways
- Strength: Regular provider follow-up described
- Strength: A broader clinical assessment is available
- Limitation: The exact supplied product needs confirming
- Limitation: No fixed universal follow-up cadence established
- Limitation: Cash costs can extend beyond the prescription
What the evidence says about this kind of treatment
The assessment above is about Defy Medical. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone seeking a clinical weight-management assessment with continuing contact rather than a medicine-only storefront.
- Wrong for
- Someone who needs an established all-in monthly amount and a specified drug product before arranging a consultation.
The evidence behind what Defy Medical prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Defy Medical compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: WillowYourEraEverPrimeMyDrHank1st Optimal24hrDOC
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does Defy accept insurance for this care?
- Its terms say it does not accept insurance. A receipt does not guarantee reimbursement from an insurer.
- Does the treatment page establish which pharmacy product I will receive?
- No single brand or compounded formulation is established for every patient by the pages reviewed. Confirm the exact prescription with the treating provider.
Sources for this review
Provider information checked . Terms can change.